Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

36 trials with published results (17%)

Research Maturity

127 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.0%

17 terminated out of 212 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

22%

47 trials in Phase 3/4

Results Transparency

28%

36 of 127 completed with results

Key Signals

36 with results88% success17 terminated

Data Visualizations

Phase Distribution

142Total
Not Applicable (53)
Early P 1 (4)
P 1 (15)
P 2 (23)
P 3 (32)
P 4 (15)

Trial Status

Completed127
Recruiting27
Unknown21
Terminated17
Withdrawn9
Active Not Recruiting5

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 127 completed trials

Clinical Trials (212)

Showing 20 of 20 trials
NCT06714448Completed

A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia

NCT07228338Early Phase 1Not Yet Recruiting

Cholinergic Enhancement of Theta

NCT04770337Not ApplicableCompleted

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

NCT06129760Not ApplicableSuspended

Glioblastoma Remote Monitoring and Care - Research Protocol

NCT03478852RecruitingPrimary

Investigating Epilepsy: Screening and Evaluation

NCT06534502Phase 4Not Yet RecruitingPrimary

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

NCT07130786Phase 2RecruitingPrimary

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

NCT03822741RecruitingPrimary

Etiology and Treatment of Neonatal Seizure

NCT07125261Phase 1Active Not Recruiting

BHV-7000 Responsive Neurostimulation System (RNS) Study

NCT07257705Not ApplicableCompleted

Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital

NCT06442748Phase 3RecruitingPrimary

Short Versus Long-term Levetiracetam in Brain Tumors

NCT06922734Active Not Recruiting

Epilepsy Watch After Vascular Events: Frequency, Outcomes, and Risk Markers

NCT06038513Not ApplicableTerminated

Transnasal Induction of Normothermia for Neurogenic Fever

NCT04259125Completed

Evaluating the Role of Inflammation in Neonatal Epileptogenesis

NCT05339126Phase 2Active Not Recruiting

RNS System LGS Feasibility Study

NCT07234695Phase 3Recruiting

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

NCT03369522CompletedPrimary

Development of an Epileptic Seizure Detection Algorithm by Continuous Analysis of the Electrocardiogram

NCT06997575Phase 4Completed

Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Eclampsia

NCT04686786Phase 2TerminatedPrimary

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

NCT07274410Not Yet Recruiting

Clinical Profile And Outcomes Of Neonatal Convulsions In The Neonatal Intensive Care Unit At Assiut University Children's Hospital

Scroll to load more

Research Network

Activity Timeline